Physician profile
Trevor Barton
NPI 1942798723
$449.96
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.62 · 2020: $114 · 2021: $213 · 2022: $27.31 · 2023: $25.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $124.14 | 2021 | |
| Akcea Therapeutics, INC. | $38.25 | 2019-2020 | |
| Eisai INC. | $38.17 | 2020-2022 | |
| Neurelis, INC. | $29.84 | 2021 | |
| Abbott Laboratories | $25.64 | 2023 | Infinity |
| Vertical Pharmaceuticals, LLC | $24.00 | 2020 | |
| Arbor Pharmaceuticals, INC. | $23.31 | 2021 | |
| Alfasigma USA, INC. | $21.28 | 2021 | |
| Acorda Therapeutics, INC | $19.92 | 2019 | |
| Avanir Pharmaceuticals, INC. | $18.29 | 2019 | |
| Tanabe Pharma America, INC. | $17.65 | 2020 | |
| Lilly USA, LLC | $16.91 | 2020 | |
| Currax Pharmaceuticals LLC | $14.16 | 2021 | |
| Allergan, INC. | $13.54 | 2020 | |
| Alexion Pharmaceuticals, INC. | $12.65 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saol Therapeutics INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.